Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
Read More
Tag: teriparatide
Richter launches Forsteo biosimilar in EU
Both products are approved in adults for osteoporosis in various indications.
Read More
Glide raises £3.2m for solid dose injector programme
Oxford, UK-based Glide Technologies has raised £3.2 million to help it progress development of a novel solid dose formulation of osteoporosis drug teriparatide (parathyroid hormone).
Read More
Trial to test fracture prevention combo in brittle bone patients
The National Institute for Health Research Efficacy and Mechanism Evaluation (EME) Programme is funding a new £1.5 million trial testing a combination of therapies to prevent rapture in patients with brittle bone disease.
Read More
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
- Gilead data show investigational HIV combination maintains viral suppression
- Verdiva Bio completes enrolment for phase 2b study of oral GLP‑1 candidate VRB‑101
- MHRA approves imlunestrant tosylate as new breast cancer treatment
